These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 22770769)

  • 1. Thrombopoietin improved ventricular function and regulated remodeling genes in a rat model of myocardial infarction.
    Chan KY; Zhou L; Xiang P; Li K; Ng PC; Wang CC; Li M; Pong NH; Tu L; Deng H; Kong CK; Sung RY
    Int J Cardiol; 2013 Sep; 167(6):2546-54. PubMed ID: 22770769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Granulocyte colony stimulating factor/macrophage colony stimulating factor improves postinfarct ventricular function by suppression of border zone remodelling in rats.
    Miki T; Miura T; Nishino Y; Yano T; Sakamoto J; Nakamura Y; Ichikawa Y; Ikeda Y; Kobayashi H; Ura N; Shimamoto K
    Clin Exp Pharmacol Physiol; 2004 Dec; 31(12):873-82. PubMed ID: 15659052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardioprotective effect of dexrazoxane in a rat model of myocardial infarction: anti-apoptosis and promoting angiogenesis.
    Zhou L; Sung RY; Li K; Pong NH; Xiang P; Shen J; Ng PC; Chen Y
    Int J Cardiol; 2011 Oct; 152(2):196-201. PubMed ID: 20692056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spironolactone modulates expressions of cardiac mineralocorticoid receptor and 11beta-hydroxysteroid dehydrogenase 2 and prevents ventricular remodeling in post-infarct rat hearts.
    Takeda M; Tatsumi T; Matsunaga S; Hayashi H; Kimata M; Honsho S; Nishikawa S; Mano A; Shiraishi J; Yamada H; Takahashi T; Matoba S; Kobara M; Matsubara H
    Hypertens Res; 2007 May; 30(5):427-37. PubMed ID: 17587755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postinfarct treatment with oxytocin improves cardiac function and remodeling via activating cell-survival signals and angiogenesis.
    Kobayashi H; Yasuda S; Bao N; Iwasa M; Kawamura I; Yamada Y; Yamaki T; Sumi S; Ushikoshi H; Nishigaki K; Takemura G; Fujiwara T; Fujiwara H; Minatoguchi S
    J Cardiovasc Pharmacol; 2009 Dec; 54(6):510-9. PubMed ID: 19755919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombopoietin protects against doxorubicin-induced cardiomyopathy, improves cardiac function, and reversely alters specific signalling networks.
    Chan KY; Xiang P; Zhou L; Li K; Ng PC; Wang CC; Zhang L; Deng HY; Pong NH; Zhao H; Chan WY; Sung RY
    Eur J Heart Fail; 2011 Apr; 13(4):366-76. PubMed ID: 21330293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p38 mitogen-activated protein kinase inhibition improves cardiac function and attenuates left ventricular remodeling following myocardial infarction in the rat.
    See F; Thomas W; Way K; Tzanidis A; Kompa A; Lewis D; Itescu S; Krum H
    J Am Coll Cardiol; 2004 Oct; 44(8):1679-89. PubMed ID: 15489104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of G-CSF on cardiac remodeling and arterial hyperplasia in rats.
    Li Y; Fukuda N; Yokoyama S; Kusumi Y; Hagikura K; Kawano T; Takayama T; Matsumoto T; Satomi A; Honye J; Mugishima H; Mitsumata M; Saito S
    Eur J Pharmacol; 2006 Nov; 549(1-3):98-106. PubMed ID: 16979158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FLT3 activation improves post-myocardial infarction remodeling involving a cytoprotective effect on cardiomyocytes.
    Pfister O; Lorenz V; Oikonomopoulos A; Xu L; Häuselmann SP; Mbah C; Kaufmann BA; Liao R; Wodnar-Filipowicz A; Kuster GM
    J Am Coll Cardiol; 2014 Mar; 63(10):1011-9. PubMed ID: 24184252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impairment of cardioprotective PI3K-Akt signaling by post-infarct ventricular remodeling is compensated by an ERK-mediated pathway.
    Miki T; Miura T; Tanno M; Nishihara M; Naitoh K; Sato T; Takahashi A; Shimamoto K
    Basic Res Cardiol; 2007 Mar; 102(2):163-70. PubMed ID: 16944359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiplatelet therapy mitigates cardiac remodeling and dysfunction in congestive heart failure due to myocardial infarction.
    Sanganalmath SK; Barta J; Takeda N; Kumamoto H; Dhalla NS
    Can J Physiol Pharmacol; 2008 Apr; 86(4):180-9. PubMed ID: 18418427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improvement in left ventricular remodeling by the endothelial nitric oxide synthase enhancer AVE9488 after experimental myocardial infarction.
    Fraccarollo D; Widder JD; Galuppo P; Thum T; Tsikas D; Hoffmann M; Ruetten H; Ertl G; Bauersachs J
    Circulation; 2008 Aug; 118(8):818-27. PubMed ID: 18678774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered melusin pathways involved in cardiac remodeling following acute myocardial infarction.
    Gu R; Zheng D; Bai J; Xie J; Dai Q; Xu B
    Cardiovasc Pathol; 2012; 21(2):105-11. PubMed ID: 21546274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of levosimendan on cardiac gene expression profile and post-infarct cardiac remodelling in diabetic Goto-Kakizaki rats.
    Vahtola E; Storvik M; Louhelainen M; Merasto S; Lakkisto P; Lakkisto J; Tikkanen I; Kaheinen P; Levijoki J; Mervaala E
    Basic Clin Pharmacol Toxicol; 2011 Nov; 109(5):387-97. PubMed ID: 21699655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of perindopril on left ventricular remodeling and myocardial osteopontin expression in rats with myocardial infarction].
    Zhang YL; Zhou SX; Wang MH; Wang JF
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Nov; 26(11):1584-8. PubMed ID: 17121705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term but not short-term p38 mitogen-activated protein kinase inhibition improves cardiac function and reduces cardiac remodeling post-myocardial infarction.
    Kompa AR; See F; Lewis DA; Adrahtas A; Cantwell DM; Wang BH; Krum H
    J Pharmacol Exp Ther; 2008 Jun; 325(3):741-50. PubMed ID: 18334667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Midkine gene transfer after myocardial infarction in rats prevents remodelling and ameliorates cardiac dysfunction.
    Sumida A; Horiba M; Ishiguro H; Takenaka H; Ueda N; Ooboshi H; Opthof T; Kadomatsu K; Kodama I
    Cardiovasc Res; 2010 Apr; 86(1):113-21. PubMed ID: 19969622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of pravastatin, fosinopril and their combination on myocardium TNF-alpha expression and ventricular remodeling after myocardial infarction in rats].
    Wei M; Gu SM; Zhang YY; Wu YH; Wu ZG
    Zhonghua Xin Xue Guan Bing Za Zhi; 2005 May; 33(5):444-7. PubMed ID: 15932706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impairment of cardiac function and remodeling induced by myocardial infarction in rats are attenuated by the nonpeptide angiotensin-(1-7) analog AVE 0991.
    Zeng WT; Chen WY; Leng XY; Tang LL; Sun XT; Li CL; Dai G
    Cardiovasc Ther; 2012 Jun; 30(3):152-61. PubMed ID: 21167013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alteration in erythropoietin-induced cardioprotective signaling by postinfarct ventricular remodeling.
    Miki T; Miura T; Yano T; Takahashi A; Sakamoto J; Tanno M; Kobayashi H; Ikeda Y; Nishihara M; Naitoh K; Ohori K; Shimamoto K
    J Pharmacol Exp Ther; 2006 Apr; 317(1):68-75. PubMed ID: 16377761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.